ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.758,64
0,41%
S&P 500
5.307,01
0,00%
Dow Jones
39.671,04
0,00%
Euro vs US Dollar
1,08514
0,24%
Bitcoin
69.747,18
0,93%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Therapix Biosciences Ltd (TRPX)

  7. Therapix Biosciences Ltd (TRPX) News

TRPX

Therapix Biosciences (TRPX)

Therapix Biosciences Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TRPX
DatumZeitQuelleÜberschriftSymbolFirma
26/06/202322h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
21/06/202315h09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/06/202315h09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
12/06/202313h03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
30/05/202322h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/05/202312h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/05/202323h31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TRPXTherapix Biosciences Ltd
08/05/202314h24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
05/05/202322h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
21/04/202315h13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
05/04/202312h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
04/04/202313h08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
10/03/202323h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
09/03/202322h16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TRPXTherapix Biosciences Ltd
27/02/202315h14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
27/02/202313h47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
17/02/202312h01Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:TRPXTherapix Biosciences Ltd
16/02/202323h25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
15/02/202314h35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
25/01/202322h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
09/01/202322h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
14/12/202222h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
07/12/202219h09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
29/11/202218h28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/11/202222h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
08/11/202213h34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
01/11/202221h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
30/09/202213h28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
16/09/202217h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
25/08/202212h56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
 Showing the most relevant articles for your search:NASDAQ:TRPX

Kürzlich von Ihnen besucht

ASX
KISRA
BINA
AUDUSDT
Australian Dollar
USOTC
HOCFF
Hochtief (PK)
USOTC
EPOKY
Epiroc Aktiebolag (PK)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten